The cell growth and survival can be regulated by cytokineinduced signals. Nevertheless, the molecular mechanisms of signal transduction from cytokine receptors to mediators of cell growth and apoptosis are not well characterized. STAT (signal transducer and activator of transcription) proteins can be activated by protein tyrosine kinases (PTK) in response to a variety of cytokines. We have shown that STAT activation induces expression of caspases which may cause cells undergo apoptosis. A hypothesis is proposed that PTK-STAT signaling pathways can regulate induction of apoptosis in response to cytokines and other extracellular signals.
Introduction
A living cell is constantly receiving and responding to a variety of extracellular signals. Important parts of these signals are polypeptides such as hormones, growth factors, cytokines, neural transmitters, antigens and cell matrix proteins. The state of cell metabolism, proliferation, differentiation, and other phenotypes is controlled by these polypeptide ligands. The signal transduction of these polypeptide ligands depends on their specific cell surface receptors. A ligand exerts its action by binding to its receptor on the cell surface and then initiating a chain of reactions within the cell through the intracellular domain of the receptor, which often contains certain enzymatic activities or/and associated with signaling proteins.
A living cell can also commit a programmed cell death or apoptosis in response to extracellular signals and internal defects, or during development and morphogenesis. 1 ± 4 A hallmark of the programmed cell death that differs from other types of cell death is the involvement of a specific set of cell death genes. Furthermore, it was known over 30 years ago that cell death during development and morphogenesis may require de novo gene expression. 5 Therefore, a specific gene expression program may also be essential for induction of apoptosis.
It is well known that signals from cell surface receptors can regulate cell survival and death. A well known cell death signaling process is shown by studies of TNF receptor/FAS (CD95) related cell surface proteins. 6, 7 Activation of TNFR/Fas may induce a signaling cascade resulting in eventual activation of proteases, followed by proteolytic reactions and destruction of a cell. The key executors of apoptosis are the caspase family of cysteine proteases 8 ± 10 which were recognized through cloning and functional analysis of the C. elegans programmed cell death gene ced-3. 2, 11 Apoptosis is also regulated by the Bcl-2 family of genes. The Bcl-2 gene was first identified by cloning of the breakpoint of the chromosome 14 ± 18 translocation, a characteristic of human follicular lymphoma. 12 Some of these family members inhibit (Bcl-2 and Bcl-xL) apoptosis while the others (Bax, Bcl-xS, Bad) accelerate death. 13 Abnormal regulation or mutations in members of Bcl-2 family genes can affect cell survival and lead to tumorigenesis. How the Bcl-2 family of genes is regulated is not clearly understood.
Although tremendous progress has been made in recent years in identifying mediators of apoptosis, and in understanding molecular and biochemical steps in the execution of apoptosis through action of`death genes,' very little is known about possible mechanisms involving regulation of the death genes, and what are the roles of the death gene expression in potentiation and induction of apoptosis. In particular, it has not been well studied whether there are signals and pathways that can control expression of death genes, and thus eventually determine the fate of a cell: death or survival.
Can the signals triggered by cytokines such as protein tyrosine kinase activation and gene expression be linked to the apoptosis? How are the expression of proteases and other`death genes' regulated? Why are some kinds of cells more sensitive to induction of apoptosis than other types of cells? Can cytokines or other signals regulate expression of death genes? It is reasonable to suspect that the`machine' for execution of apoptosis, such as caspase family proteins, can be regulated by specific transcription factors, which could be further modulated by cytokine-triggered signaling pathways. In other words, regulation of these death genes may provide a clue as to how the activation of specific signal transduction programs leading to death induction is achieved. The extent of death gene expression or repression might determine the fate of a cell: death or survival, or at least, the sensitivity of a cell to induction of apoptosis. Despite identification of many of the important players in the apoptosis process, there is much to learn about how these death genes are regulated.
Recently, it has been revealed that STAT (Signal Transducer and Activator of Transcription 14, 15 can regulate gene expression of caspases and induce apoptosis in response to activation of protein tyrosine kinases (PTKs). 16, 17 These recent findings may provide a clue for the hidden mechanisms of potentiation and induction of apoptosis through regulation of caspase gene expression. Since the PTK-STAT pathway can be activated during cellular responses to polypeptide ligands, pathogens and other stimuli, it is tentative to postulate that regulation of apoptosis through this pathway may have a wide role in many pathological and physiological processes including degenerative diseases, and during development and morphogenesis.
In consideration of the readership of this article, I will first review briefly the history of discovering the PTK-STAT pathway, then I will discuss recent progress in understanding of cytokine and PTK-induced apoptosis. A hypothesis is proposed concerning the mechanism of PTK-induced apoptosis. I will also discuss the significance of this STAT-caspase connection in regulation of the programmed cell death.
PTK activation induces diverse signaling pathways and cellular effects
The central question is whether and how other cell surface receptors could regulate programmed cell death besides thè death receptors.' Many growth factors and cytokines transduce signals through activation of protein tyrosine kinases (PTKs). Most growth factor receptors contain intrinsic tyrosine kinase domains, whereas cytokine receptors can be associated with cytoplasmic tyrosine kinases. 18, 19 Through some mediators or adapters, the tyrosine kinases can further activate a series of downstream serine/threonine kinases. These serine/threonine kinases in turn can stimulate effectors such as transcription factors in the cytoplasm and nucleus (reviewed in 20, 21 ). A vast amount of evidence indicates that kinase cascade pathways play important roles in mediating cell proliferation, differentiation and survival. For example, activation of PTKs through ligand-mediated receptor dimerization can result in the activation of a number of downstream signaling pathways, including PI3 kinase pathway and Ras-Raf-MAP kinase pathways. The PI3 kinase and MAP kinase are believed to mediate cell survival and mitogenic responses. 18, 20, 22 Most cytokines and growth factors can activate the PTK-Ras-MAP kinase and PTK-PI3 kinase pathways; thus, they can act as mitogens for a variety of cells.
Furthermore, deprivation of growth factors or cytokines can result in either cell growth arrest or apoptosis. Thus, growth factors, such as insulin-like growth factor-1 (IGF-1), EGF and PDGF are also regarded as survival factors. Many downstream signaling proteins, such as Ras, Raf, and nuclear transcription factors, such as Fos, Jun, Myc etc., have been shown to be oncogenes. 21 Thus PTK signaling is generally believed to be involved in promoting proliferation and survival.
On the other hand, in contrast to the above concept that PTK signaling is involved in positive regulation of cell growth and survival, it is well documented that some PTKactivating growth factors and cytokines can induce apoptosis. Among them, interferon (IFN) can trigger cell cycle arrest and cell death. 23 Furthermore, it is puzzling that EGF, which is an important growth factor, can also induce apoptosis in some mammalian cells. 24, 25 Additionally, many other cytokines such as IL-2 and IL-6, may also have the potential to induce apoptosis. 26, 27 Therefore, cytokines and PTK signal transduction may have dual, positive and negative, effects on cell growth and survival.
Protein tyrosine kinase (PTK)-STAT pathway
Studies on the mechanism of interferon-induced gene expression reveals a direct signaling pathway from cell surface receptors to the transcription factors (for review see 14, 15, 19 ). In this pathway, the signal is mediated by STAT proteins which contain Src homology region 2 (SH2) domains and can bind directly to the tyrosine phosphorylated receptors.
28 ± 31 STAT proteins are then phosphorylated and activated in the cytoplasm by PTKs, such as JAK tyrosine kinases. 28,29,32 ± 36 The activated transcription factors then translocate to the nucleus, joined by a nuclear DNA binding factor to form an active transcriptional complex. 14, 37, 38 Although this signaling pathway was first revealed in the interferon system, it has been further demonstrated that most cytokines and growth factors, including EGF, PDGF, CSF-1, insulin, IL-2, IL-3, IL-4, IL-5, IL-6, IL-7, IL-9, IL-10, IL-11, IL-12, CSF, GM-CSF etc., can activate the direct STAT signaling pathway. 19, 29, 35, 39 ± 47 So far more than six members of the STAT protein family have been identified in higher eukaryotes, and these STAT proteins are believed to respond specifically to different cytokine and other extracellular signals. 19, 48 The Jak family tyrosine kinases were initially recognized as activators of STAT proteins. 33 ± 36 However, a variety of tyrosine kinases, such as EGF receptor tyrosine kinase and Src kinase have been shown to activate STAT proteins directly and independently of JAK kinases. 29, 49, 50 Our recent work has further shown that FGF receptor tyrosine kinase, Lck kinase, focal adhesion kinase (FAK) and many other tyrosine kinases can also activate STAT proteins, 51, 52 (Xie and Fu, unpublished results). It is possible that most protein tyrosine kinases have the potential to activate the STAT pathway under physiological conditions. Therefore, the PTK-STAT pathway may be a general route of signaling in response to a variety of polypeptide ligands and other stimuli.
From PTK-STAT to induction of caspases and apoptosis
After the initial discovery of the STAT signaling pathway, it is necessary to address several important questions about cellular functions of the STAT pathway. First, can activation of STAT proteins affect cell cycle control? It was first observed that some cell lines, such as A431 and MDA-MB-468, cells were growth inhibited by treatment of EGF. In these cell systems, EGF can activate STAT proteins at the same level as IFNs. Therefore, it was speculated that STAT activation by EGF and IFNs may cause cell growth arrest. In other words, the STAT pathway may have a negative role in regulation of cell growth. Experiments using STAT1-deficient cell lines have shown that STATs, in particular Stat1, can negatively regulate cell growth. 16, 53 Interestingly, it was shown that cell cyclin inhibitors, such as p21/WAF1, can be upregulated through the STAT pathway and result in eventual cell growth arrest. 16, 54 ± 57 Furthermore, it was noticed that the STAT activation may not only cause cell growth arrest, but also increase cell death in response to cytokine treatment. 16 The initial observation we had was the correlation of apoptosis induction with the STAT activation in a number of cell lines that over express EGF receptor. Normally, in many types of cell lines, probably due to a specific inhibitor, EGF does not activate STATs. 58 However, EGF receptor autophosphorylation and MAP kinase activity are all the same in all these`conventional' cell lines. Interestingly, in some cancer cell lines that over-express the EGF receptor (such as A431 and MDA-MB-468 cells), that can probably override the potential inhibitor for STAT activation, EGF activates the STAT pathway. Correlated with STAT activation, these cells undergo apoptosis after EGF treatment. 17 It was necessary to explore the cellular target(s) of the activated STAT for apoptosis induction. Among many genes we tested, ICE (Caspase-1) expression was most significantly upregulated in a STAT-dependent manner after either IFN-g or EGF treatment. Additionally a proteolytically cleaved form of ICE, p10, was also clearly observed in this cytokine induced apoptosis. The conclusive evidence for STAT-induced caspase and apoptosis was obtained using STAT-deficient cell lines. It was demonstrated that the Stat1 protein was defective in U3A cells. 59, 60 In these mutant cells, IFN-g treatment did not induce ICE gene expression. However, once a single gene of STAT1 was reintroduced into these cells, IFN-g restored its ability to induce ICE and apoptosis. Thus, we concluded that the STAT pathway is essential for the induction of caspase expression and apoptosis by IFN-g. 17 Furthermore, these observations suggested a general model that the induction of caspase genes may be involved in cytokine-induced apoptosis. Our recent results have also indicated that several other caspases can also be upregulated through the STAT pathway (Asao and Fu, unpublished results). It is also reported that Stat1 may be required for constitutive expression of caspases, although the classical functions of Stat1 were believed not to be required. 61 This basal level of caspases was necessary for induction of apoptosis by death signals such as TNF-a 16 (Chin and Fu, unpublished observation) . It was also shown that FAS and FAS ligand may also be upregulated by IFNs, possibly through Stat 1.
62, 63 We have recently observed that activation of STAT5 can cause increased apoptosis in activated T cells. 52 It is possible that STAT5 and other STAT proteins can also regulate genes involving apoptosis.
Further unsolved questions
Several important issues concerning the conclusions above should be further clarified here. First, we do not know at this point how the ICE gene or other caspase gene is regulated by the STAT proteins. In MDA-MB-468 cells, ICE mRNA was quickly induced (within 1 h), indicating that STAT may directly regulate ICE gene expression. Since ICE gene induction could be much slower in other (such as A431) cells, an indirect regulatory mechanism might be involved. One possibility is through action of interferon regulatory factor-1, (IRF-1). 64 It was shown that IRF-1 was one of the primary genes induced by cytokines through the STAT pathway.
65,66 IRF-1 is believed required for ICE induction in response to radiation and DNA damage. 67 We have identified several STAT binding site (SIE) or ISRE (interferon stimulated responsive element)-like sequences within 1 Kb of the 5'-flanking region of the ICE gene. However, the functional roles of these promoter elements are not fully characterized.
We have shown that apoptotic response in ICE 7/7 cells was greatly reduced after IFN-g treatment. 17 This observation may constitute evidence for the requirement for ICE in IFN-g-induced cell death. Furthermore, although ICE is not essential for development as shown in ICE 7/7 mice, 68, 69 it is involved in apoptosis resulting from several signals. For instance, ICE is involved in DNA damage-induced and IRF-1-mediated apoptosis. 69 Fas-induced apoptosis, 68 granzyme B-induced apoptosis, 70 degradation of basement membrane extracellular matrix (ECM)-induced apoptosis in mammary epithelial cells, 71 and spontaneous cell death of thymocytes (T Zheng and R Flavell, personal communication), and related in caspase 11-mediated apoptosis. 72 The convincing data were also obtained recently showing ICE is required for apoptosis of sensory neurons after growth factor withdrawal. 73 It is very likely that elevated expression of ICE by cytokine treatment will lead to caspase activation and eventually cell death. However, while ICE expression is involved in the EGF-and IFN-ginduced apoptosis as we have shown, the data do not imply that the up-regulation of the ICE gene alone is sufficient. Additionally, ICE is the first, but may not be the only caspase we have found to be regulated by the PTK-STAT signaling. Other members of caspases and other death genes may also be targets of regulation (Asao and Fu, unpublished data). For example, FAS and FAS ligands are also the possible targets genes of STAT proteins. 63 Therefore, there must be multiple target genes in STATmediated apoptosis induction. Therefore the regulation of ICE by the STAT pathway can be regarded as the first evidence for a new hypothesis: the PTK-STAT pathway can regulate apoptosis.
Although in our initial systems we have first shown that Stat1 is involved in apoptosis induction in response to IFN and EGF, it by no means implies that Stat1 is the sole member in the STAT family that has the potential for apoptosis induction. It is very likely that under different situations, other members of STATs may well play roles in apoptosis induction. Among other STAT proteins, STAT3 may well play a role in IL-6 induced apoptosis. 74 Thus function of Stat1 could serve as a paradigm for the more general roles of other STATs. Moreover, although some caspases such as CPP32/caspase-3 may not be regulated by STAT proteins, 17 its enzymatic activities may be activated by other caspases. The possible redundant functions of different members of STATs and caspases may provide an explanation to the observation that a single null mutation of one member of STATs or caspases may not cause significant defects in development. 68, 69, 75, 76 Since the PTK-STAT pathway plays essential roles in cellular responses to many pathological and physiological stimuli, it is possible that some diseases or developmental defects resulting from inappropriate cell arrest and apoptosis may be due to an overactive PTK-STAT pathway. Like JAK and EGF receptor kinases, focal adhesion kinase (FAK) and fibroblast growth factor (FGF) receptor tyrosine kinase can also activate Stat1 and induce apoptosis. In particular, we have observed STAT activation by integrin-FAK signaling. Under the normal conditions, the STAT activation does not trigger apoptosis because it is rather weak and the surviving signals are strong in response to PTK activation. However, when survival signal was reduced by serum withdrawal, the negative effect induced STAT activation may promote apoptosis (see below).
The molecular mechanisms of the dual activities of cytokines in cell growth and survival
We have suggested that the STAT activation by protein tyrosine kinases can induce the expression of caspases and cause apoptosis. The model systems that were used are interferon and EGF responsive cells. However, do these findings have any general significance?
Many growth factors and cytokines have dual effects on cell growth and survival. 77 IL-6 stimulates hepatocyte proliferation and prevents apoptosis; but IL-6 inhibits cell growth and induces apoptosis in some myeloma cell lines, and in terminally differentiated B-cells. 74, 78 Like EGF, PDGF is required for proliferation and survival in many types of cells but also inhibits cell growth and accelerates apoptosis in some other cells. 79 What is the molecular basis responsible for the dual functions of cytokines? A working model is that every PTKactivating cytokine simultaneously initiates multiple signaling pathways that may have opposite, positive and negative, effects on cell growth. Thus whether a cytokine promotes or inhibits cell growth is determined by the relative strengths of positive or negative signals that may be induced intrinsically by the same cytokine-bound receptor. In particular, activation of the Ras-MAP kinase and PI3-Akt kinase pathways promote cell growth/survival. In contrast, activation of the STAT pathway, especially STAT1 protein, may result in cell arrest/death by induction of CDK inhibitors and caspases. The intracellular homeostasis requires a balance between growth/survival and arrest/death signaling events. Different cells may have different dynamic states and hence different phenotypic outputs.
Take EGF as an example, EGF does not activate the STAT pathway in many types of cells, 58 but EGF does trigger the MAP kinase pathway etc., in these cells. Therefore, the positive signals are dominant, and these cells proliferate and survive in response to EGF. However, in A431 or MDA-MB-468 cells, the STAT pathway is more sensitive in response to EGF, so CDK inhibitors and the caspase can be highly induced, which may override the positive signals and result in cell arrest and death. Therefore, EGF can conditionally activate a negative signaling pathway through STAT activation and expression of CDK inhibitors and caspases in cells like A431 and MDA-MB-468.
Thus, the polypeptide ligand-activated PTK signaling could not only transduce the proliferative and surviving signals, as most commonly observed, but also, under some conditions, generate anti-proliferative and cell death signals that are mediated by the STAT proteins, STAT1 in particular. This conclusion may provide a possible explanation for the dual functions of many cytokines and growth factors.
Interestingly, TNF-a signaling was also found to initiate at least two opposing pathways: induction of apoptosis through the activation of a protease cascade and activation of transcription factor NF-kB which suppresses apoptosis. 80 ± 83 However, unlike TNF-a-induced apoptosis in which gene expression may not be directly required, PTK-STAT-induced apoptosis processes require coordinate expression of specific gene(s), such as caspases.
Puzzles and questions of apoptosis induction after serum withdrawal
The new concept that PTK signaling itself can lead to apoptosis, may have further implications for the unsolved puzzle that cell death can be triggered by growth factor deprivation, and`spontaneous' apoptosis during development and morphogenesis and some human degenerative diseases.
It is important to determine the mechanisms of cell death when the necessary cytokines, growth factors, or cell matrix proteins are not provided. This induction of apoptosis after growth factor withdrawal has been believed to be due to à default' mechanism. 84 According to this notion, cells can only survive when growth factors are provided to suppress this mechanism to die. What is the molecular basis of this default mechanism? Can this`default' be regulated and affected by signaling pathways? What are the mediators that carry out this default mechanism? None of these questions have answers yet.
The cell death induced by growth factor deprivation may also involved in development. Lack of growth factors or other stimuli is believed to be responsible for organogenesis and maintenance of homeostasis of the whole body. Furthermore, many kinds of degenerative diseases are believed to be caused by`spontaneous' apoptosis, an event resembling cell death triggered by growth factor withdrawal.
A critical question is whether the molecular mechanism of the apoptosis induced by cytokine treatment can also mediate the cell death or apoptosis triggered by cytokine deprivation. What are the hidden molecular mechanisms controlling the induction of apoptosis in either the presence or the absence of cytokines and growth factors? Could these two seemingly opposite observations, death induced by cytokine deprivation or death through treatment of cytokines in some cells, have a common molecular basis?
A hypothesis on apoptosis induced by growth factor withdrawal As I mentioned in the previous sections, many studies of signal transduction to apoptosis have focused on TNF/FAS mediated apoptosis that may not require de novo gene expression. However, more and more cases have been documented in which the induction of apoptosis under many conditions may involve distinctive signals other than those elicited by TNF/ FAS. One of most striking examples is induction of apoptosis after the deprivation of growth factor or other survival factors. Their signals are apparently different from those by TNF/FAS: it is a slower process, and the up or down regulation of certain genes is possible. However, little was known about the mechanisms and possible signaling process. Although the concept of apoptosis by default is an attractive model, it did not provide the molecular basis for the`default.' For example, what are the specific signals and executors that may be responsible for the intrinsically hard-wired machine for induction of apoptosis? In other words, there must be certain mediators or gene products to carry out the death execution after survival factor deprivation, based on the view that apoptosis is an active process. What are these potential genes? Most interestingly, can expression of these death genes be regulated by certain signaling pathways? It is known that for different types of cells there are significant differences in their sensitivities or thresholds for apoptosis induction by default. 3 Then how are these thresholds for apoptosis induction determined? These are significant and fundamental questions. If we can find clues for the apoptosis induction by this default mechanism after survival signal withdrawal, it may provide mechanisms for many important situations of apoptosis induction during stages of development or in the pathogenesis of auto immune disorders, leukemia, and some degenerative diseases, and for many other types of`spontaneous' apoptosis.
Here, I propose a hypothesis that the PTK-STAT signaling pathway may be an essential player in induction of apoptosis by default after the withdrawal of the survival signal. As I have shown above, the PTK-STAT pathway can mediate induction of apoptosis through the regulation of caspases and other cell death genes. Under the conditions we used, the PTK-STAT can be strongly activated and the induction of caspases is high. Therefore, the survival signals from PTK are overcome by the effects of STAT activation and upregulated caspases, causing apoptosis. However, in normal cell culture conditions without a large amount of cytokines, STAT proteins may only . Thus the differences between positive and negative signals after growth factor withdrawal can be a decisive factor for the balance shifting to death. In this model, the hard-wired, intrinsic executioner or mediator (THE DEFAULT) of apoptosis is the low level of STAT and caspase activities regulated by STAT. Furthermore, the differences in the thresholds for induction of apoptosis may be determined by the different levels of STAT and caspase activities. Once the survival signals for suppressing these death mediators are weakened after growth factor withdrawal, it is the turn for action of STAT and caspase and other death genes, and the apoptosis occurs.
A brief summary and perspectives
We are at the beginning of understanding of the STAT functions in control of apoptosis. The hypothesis proposed above is only one possible example. I summarize some thoughts on possible STAT functions in apoptosis shown in Figure 1 and give some perspectives as follows: (1 52 the defect in apoptosis induction should be still observable. I expect that more thorough analysis of STAT-de®cient mice during the development and under relevant physiological and pathological conditions will reveal more evidence on the critical role of STAT proteins in apoptosis induction. As transcription factors, STAT proteins may regulate directly genes that are involved in induction of apoptosis in response to the PTK activation. However, it is also likely that STAT proteins may control and activate other transcription factors, such as IRF-1, that will further regulate apoptosis genes such as caspases. STAT proteins may cause expression of death genes, resulting in higher sensitivity to apoptosis induction, it is possible that STAT proteins may also regulate genes that suppress induction of apoptosis. It is reported that Bcl-xL, a gene involved in cell survival, may be an immediate gene regulated by STAT proteins, 85, 86 (Welte and Fu, unpublished observations). Furthermore, cyclin D family members were shown to be directly regulated by STAT. 87 In contrast to these early genes which are transiently induced by STAT, caspase gene induction through STAT is often a late and lasting process (mainly ranges from 1 to 48 h depending on cell types) 17 (Asao and Fu, unpublished results). Thus, when a cytokine or other ligand activates PTKs, initial functions of PTK-STAT activities may facilitate cell survival and proliferation. If the stimulation continues and is further intensi®ed, the later genes, including death genes, are expressed, which may overcome the effects of the early genes, resulting in termination of initial functions, and often, induction of apoptosis. This is a possible timely and ef®cient self-controlled mechanism of cells: The same signal, the PTK-STAT activation in response to cytokines and other polypeptide ligands, is contributing to both activation and destruction of the cell. Furthermore, the dual functions of the PTK-STAT pathway in regulating both survival/ proliferative and death genes may also provide a molecular mechanism for the widely-observed dual effects of cytokines and other polypeptide ligands for promoting cell proliferation/survival or for cell death.
